Prelude Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400K | Sell |
|
|||||
|
2025
Q1 | $1.2M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $642K | Buy |
|
|||||
|
2024
Q2 | $300K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.16M | Buy |
|
|||||
|
2023
Q3 | $546K | Sell |
|
|||||
|
2023
Q2 | $1.19M | Sell |
|
|||||
|
2023
Q1 | $1.61M | Buy |
|
|||||
|
2022
Q4 | $1.3M | Sell |
|
|||||
|
2022
Q3 | $1.21M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $885K | Buy |
|
|||||
|
2021
Q3 | $698K | Buy |
|
|||||
|
2021
Q2 | $481K | Buy |
|
|||||
|
2021
Q1 | $385K | Buy |
|
|||||
|
2020
Q4 | $321K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $458K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $593K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $71K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $48K | Hold |
|
|||||
|
2014
Q4 | $38K | Sell |
|
|||||
|
2014
Q3 | $624K | Hold |
|
|||||
|
2014
Q2 | $601K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $591K | Hold |
|
|||||
|
2013
Q3 | $548K | Sell |
|
|||||
|
2013
Q2 | $884K | Buy |
|